Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer. Biomol Biomed [Internet]. 2022 Jul. 29 [cited 2024 May 2];22(4):553-9. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/6450